logo

Talaris Therapeutics, Inc (TALS)



Trade TALS now with
  Date
  Headline
11/30/2021 7:10:50 AM Talaris Therapeutics Begins Phase 2 FREEDOM-3 Trial In Diffuse Cutaneous Systemic Sclerosis